Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BAYER

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 50
  • 0 comments

FDA approve NAPROXEN SODIUM

Comment Full text

PRINSTON INC

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 43
  • 0 comments

FDA approve BUSULFAN

Comment Full text

SOMERSET

  • FDA Approval
  • Sept. 12, 2024, 04:27 UTC
  • 39
  • 0 comments

FDA approve BRIMONIDINE TARTRATE; TIMOLOL MALEATE

Comment Full text

MYLAN

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 46
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

BAXTER HLTHCARE CORP

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 50
  • 0 comments

FDA approve CIPROFLOXACIN

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 53
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

INCEPTA PHARMS LTD

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 47
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

NOVEL LABS INC

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 48
  • 0 comments

FDA approve DEXMETHYLPHENIDATE HYDROCHLORIDE

Comment Full text

TEVA

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 47
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

HALEON US HOLDINGS

  • FDA Approval
  • Sept. 10, 2024, 18:13 UTC
  • 52
  • 0 comments

FDA approve DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN

Comment Full text
  • Previous
  • 357
  • 358
  • 359
  • 360
  • 361
  • Next

Search

News categories

  • Technical Exchange News(11504)
  • Event(3374)
  • SEC News(216352)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137524)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin